The Trojan horse of off-label glucagon-like peptide-1 receptor agonist use: Protecting patients through responsible practice

Andrej Belančić, Bojan Jelaković

Open source

DOI
10.1177/03000605261458168
Published
2026-06
Container
Journal of International Medical Research
Publisher
SAGE Publications
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1177/03000605261458168,
  title = {The Trojan horse of off-label glucagon-like peptide-1 receptor agonist use: Protecting patients through responsible practice},
  author = {Andrej Belančić and Bojan Jelaković},
  year = {2026},
  journal = {Journal of International Medical Research},
  doi = {10.1177/03000605261458168},
  url = {https://doi.org/10.1177/03000605261458168}
}

RIS

TY  - JOUR
TI  - The Trojan horse of off-label glucagon-like peptide-1 receptor agonist use: Protecting patients through responsible practice
AU  - Andrej Belančić
AU  - Bojan Jelaković
PY  - 2026
JO  - Journal of International Medical Research
DO  - 10.1177/03000605261458168
UR  - https://doi.org/10.1177/03000605261458168
ER  - 

APA

Belančić, A., & Jelaković, B. (2026). The Trojan horse of off-label glucagon-like peptide-1 receptor agonist use: Protecting patients through responsible practice. Journal of International Medical Research. https://doi.org/10.1177/03000605261458168

Source records